Alogliptin N-Formyl Impurity - Request Quote
Alogliptin N-Formyl Impurity
| SZ CAT No: | SZ-A053093 |
| CAS No | NA |
| Mol.F. | C19H21N5O3 |
| Mol.Wt. | 367.4 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Alogliptin N-Formyl Impurity is chemically (R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)formamide. Alogliptin N-Formyl Impurity is supplied with detailed characterization data compliant with regulatory guideline. Alogliptin N-Formyl Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Alogliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Alogliptin N-Formyl Impurity
Purchase Alogliptin N-Formyl Impurity
Alogliptin N-Formyl Impurity suppliers
Alogliptin N-Formyl Impurity manufacturers
Alogliptin N-Formyl Impurity price
Order Alogliptin N-Formyl Impurity
Enquire Alogliptin N-Formyl Impurity
Alogliptin N-Formyl Impurity cost
Alogliptin N-Formyl Impurity Supplier
Alogliptin N-Formyl Impurity Distributor
Alogliptin N-Formyl Impurity for Method Validation
Alogliptin Reference Standard
Alogliptin N-Formyl Impurity for ANDA Filing
Alogliptin N-Formyl Impurity for Forced Degradation Studies
Alogliptin N-Formyl Impurity Identification Standards
Alogliptin N-Formyl Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.